DK158310C - Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved - Google Patents

Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved

Info

Publication number
DK158310C
DK158310C DK407383A DK407383A DK158310C DK 158310 C DK158310 C DK 158310C DK 407383 A DK407383 A DK 407383A DK 407383 A DK407383 A DK 407383A DK 158310 C DK158310 C DK 158310C
Authority
DK
Denmark
Prior art keywords
pyrimidines
diamino
piperazinyl
intermediates
preparing substituted
Prior art date
Application number
DK407383A
Other languages
English (en)
Other versions
DK407383A (da
DK158310B (da
DK407383D0 (da
Inventor
Leslie M Werbel
Jocelyn H Hung
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK407383D0 publication Critical patent/DK407383D0/da
Publication of DK407383A publication Critical patent/DK407383A/da
Publication of DK158310B publication Critical patent/DK158310B/da
Application granted granted Critical
Publication of DK158310C publication Critical patent/DK158310C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK407383A 1982-09-09 1983-09-08 Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved DK158310C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41640482A 1982-09-09 1982-09-09
US41640482 1982-09-09
US52065383 1983-08-09
US06/520,653 US4532240A (en) 1982-09-09 1983-08-09 Diaminopyrimidines

Publications (4)

Publication Number Publication Date
DK407383D0 DK407383D0 (da) 1983-09-08
DK407383A DK407383A (da) 1984-03-10
DK158310B DK158310B (da) 1990-04-30
DK158310C true DK158310C (da) 1990-10-15

Family

ID=27023342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK407383A DK158310C (da) 1982-09-09 1983-09-08 Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved

Country Status (9)

Country Link
US (1) US4532240A (da)
EP (1) EP0103464B1 (da)
AU (2) AU560971B2 (da)
CA (1) CA1251447A (da)
DE (1) DE3378469D1 (da)
DK (1) DK158310C (da)
ES (2) ES8502989A1 (da)
GR (1) GR79058B (da)
IE (1) IE56148B1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
HUT64323A (en) * 1992-06-09 1993-12-28 Richter Gedeon Vegyeszet Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives
ATE166347T1 (de) * 1993-02-26 1998-06-15 Max Delbrueck Centrum Verfahren zur herstellung von c-nukleosiden und c-nukleosid-analoga, neue c-nukleoside und c- nukleosid-analoga, sowie ihre verwendung
DE4320570C2 (de) * 1993-02-26 2002-07-11 Max Delbrueck Centrum Verfahren zur Herstellung von C-Nukleosiden und C-Nukleosid-Analoga, neue C-Nukleoside und C-Nukleosid-Analoga sowie deren Verwendung
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
AU2076299A (en) 1998-01-30 1999-08-16 Meiji Seika Kaisha Ltd. Phenylpiperazine derivatives as integrin alphavbeta3 antagonists
US20040006042A1 (en) * 1998-08-13 2004-01-08 Berry David Allen Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers
AU4690999A (en) * 1998-08-13 2000-03-06 Warner-Lambert Company Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers
BR0209932A (pt) * 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
GB0412072D0 (en) * 2004-05-28 2004-06-30 Syngenta Participations Ag Chemical compounds
JP6949055B2 (ja) * 2016-02-05 2021-10-13 ヴェラ ファーマシューティカルズ,エルエルシー 感染症を治療するための組成物および方法
WO2019032458A1 (en) * 2017-08-07 2019-02-14 Vyera Pharmaceuticals, LLC DHFR INHIBITORS, COMPOSITIONS AND RELATED METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US416404A (en) 1889-12-03 Automatic lath-feeder for paper-carriers
BE485737A (da) * 1947-11-12
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
AT340933B (de) * 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines

Also Published As

Publication number Publication date
ES531004A0 (es) 1985-05-01
EP0103464A3 (en) 1985-07-03
DK407383A (da) 1984-03-10
AU6878787A (en) 1987-05-14
US4532240A (en) 1985-07-30
CA1251447A (en) 1989-03-21
GR79058B (da) 1984-10-02
EP0103464B1 (en) 1988-11-17
ES525490A0 (es) 1985-02-01
AU568997B2 (en) 1988-01-14
ES8502989A1 (es) 1985-02-01
DK158310B (da) 1990-04-30
DE3378469D1 (en) 1988-12-22
IE831920L (en) 1984-03-09
AU1869983A (en) 1984-03-15
EP0103464A2 (en) 1984-03-21
DK407383D0 (da) 1983-09-08
IE56148B1 (en) 1991-05-08
AU560971B2 (en) 1987-04-30
ES8504775A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
DK425583A (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaaden
DK159442C (da) Analogifremgangsmaade til fremstilling af 6,7-substitueret-4-ethyl-quinazoliner
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK219382A (da) Fremgangsmaade til fremstilling af 1,2-diaminocyclobuten-3,4-dioner
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
DK160939C (da) Analogifremgangsmaade til fremstilling af benzisothiazol- og benzisoxazolpiperazinderivater, samt mellemprodukter til anvendelse ved fremgangsmaaden
DK156479C (da) 2-(2-fluor-4-halogen-5-substitueret-phenyl)-hydantoinderivater
DK32684D0 (da) Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
FI824443L (fi) 2-/4-/(4,4-dialkyl-2,6-piperidindion-1-yl)-butyl/-1-piperazinyl/pyrimidiner
DK369483D0 (da) Stabiliseret herbicidsammensaetning samt fremgangsmade til fremstilling af samme
DK382785A (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK128585A (da) Fremgangsmaade til paavisning af uautoriseret brug af en identifikation
DK410383A (da) Poroest polytetrafluorethylenmateriale samt fremgangsmaade til fremstilling af samme
DK533186A (da) Haette til perkutan indretning samt fremgangsmaade til brug af haetten
DK107482A (da) Fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK184579A (da) Estere af substituerede 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK491983A (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling af samme
DK161071C (da) Analogifremgangsmaade til fremstilling af 3,3-dialkyl-indolinderivater samt mellemprodukter til anvendelse herved
DK517282A (da) 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylethylsubstituerede piperazinderivater samt fremgangsmaader til fremstilling af samme
IT1172073B (it) Procedimento per la preparazione di buspirone
DK283383D0 (da) Fremgangsmade til fremstilling af 6'-aminopenicillanoyloxymethylpenicillanat-1,1-dioxid og mellemprodukter anvendelige til fremgangsmadens udoevelse
DK214479A (da) Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner
DK317182A (da) Fremgangsmaade til fremstilling af pyrimidinoxider
ES512472A0 (es) Un procedimiento para la preparacion de 3(2-(3-alquil y alquenil-4-piperidil))indoles.
DK166081A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner

Legal Events

Date Code Title Description
PUP Patent expired